Diuretics in the Treatment of Heart Failure: Mainstay of Therapy or Potential Hazard?

Journal of Cardiac Failure

Volumn 12, Issue 5, 2006, Pages 333-335

  Krum, Henry ^a   Cameron, Peter ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; HORMONE RECEPTOR BLOCKING AGENT; NATRIURETIC FACTOR; NESIRITIDE; NEUROHORMONE; NONPOTASSIUM SPARING DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; UNCLASSIFIED DRUG; URODILATIN; VASOPRESSIN RECEPTOR ANTAGONIST;

CLINICAL TRIAL; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EDITORIAL; HEART FAILURE; HEART FUNCTION; HOSPITALIZATION; HUMAN; MORTALITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUDDEN DEATH;

CARDIOTONIC AGENTS; DIURETICS; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS;

EID: 33744517552     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.05.001     Document Type: Editorial

References (20)

1. Slater J.D.H., and Nabarro J.D.N. Clinical experience with chlorothiazide. Lancet 1 (1958) 124-126
2. Silke B. Diuretic induced changes in symptoms and quality of life. Br Heart J 72 2 Suppl (1994) S57-S62
3. Haerer W., Bauer U., Sultan N., et al. Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure-a placebo-controlled trial. Cardiovasc Drugs Ther 4 (1990) 515-521
4. Richardson A., Bayliss J., Scriven A.J., et al. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet 2 (1987) 709-711
5. Faris R., Flather M., Purcell H., et al. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 82 (2002) 149-158
6. Komajda M., Follath F., Swedberg K., et al. Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24 (2003) 464-474
7. Stevenson L.W., Brunken R.C., Belil D., et al. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol 15 (1990) 174-180
8. Sharpe N., Murphy J., Smith H., and Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1 (1988) 255-259
9. Cooper H.A., Dries D.L., Davis C.E., Shen Y.L., and Domanski M.J. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100 (1999) 1311-1315
10. Domanski M., Tian X., Haigney M., and Pitt B. Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Failure 12 (2006) 327-332
11. Ikram H., Chan W., Espiner E.A., and Nicholls M.G. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci (Lond) 59 (1980) 443-449
12. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
13. Rajagopalan S., and Pitt B. Aldosterone as a target in congestive heart failure. Med Clin North Am 87 (2003) 441-457
14. Iyengar S., Feldman D.S., Trupp R., and Abraham W.T. Nesiritide for the treatment of congestive heart failure. Expert Opin Pharmacother 5 (2004) 901-907
15. Mitrovic V., Luss H., Nitsche K., et al. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial. Am Heart J 150 (2005) 1239.e1-1239.e8
16. Welch W.J. Adenosine type 1 receptor antagonists in fluid retaining disorders. Expert Opin Investig Drugs 11 (2002) 1553-1562
17. Goldsmith S.R., and Gheorghiade M. Vasopressin antagonism in heart failure. J Am Coll Cardiol 46 (2005) 1785-1791
18. Grinstead W.C., Francis M.J., Marks G.F., et al. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 73 (1994) 881-886
19. Graham C.A. Pharmacological therapy of acute cardiogenic pulmonary oedema the emergency department. Emerg Med Australas 16 (2004) 47-54
20. Peter J.V., Moran J.L., Phillips-Hughes J., Graham P., and Bersten A.D. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet 367 (2006) 1155-1163